ABBV

AbbVie

AbbVie (ABBV)

NYSE
65.840.40 (0.61%)Updating Price
Delay +15 min
Stock ratings and Insider transaction returns are measured over a
period with
benchmark.
Learn how to set expert rankings:
Investment time frame (1 Year)
TipRanks measures the stock performance over a one-year time period. For Corporate Insiders, this period is measured starting from the transaction date. You can see how well experts have performed on longer, or shorter, time periods by setting this parameter. Now you can conclude if you are taking advice from the right expert.
Benchmark comparison (No Benchmark)
TipRanks allows you to compare each recommendation, or Corporate Insider transaction to the performance of the S&P 500, or to the sector of the company, to determine if the Expert, or Insider outperforms the market or not.
Reset to default Settings
Details

Analysts Covering AbbVieAnalyst Ratings

Showing:

Analyst Consensus

Moderate Buy

Based on 6 Analyst Ratings


  • 3 Buy
  • 3 Hold
  • 0 Sell

Based on 6 Wall Street analysts offering recommendations for ABBV in the last 3 months (by analysts ranked 0 to 5 stars).

Analyst Price Target on ABBV

Average Price Target

$76.07

(15.54% Upside)

Based on 6 analysts offering 12 month price targets for ABBV in the last 3 months. The average price target is $76.07 with a high estimate of $90.00 and a low estimate of $65.00.

Filters

Position

Action

Ranking

UpgradeUpgrade to see the 5 most recent recommendations
Analyst Ratings
Article
BMO Capital
3.8 out of 5
BMO Capital
3.8 out of 5
Hold
-
-
Reiterated
Credit Suisse
3 out of 5
Credit Suisse
3 out of 5
Hold
$65.00
$65.00
Reiterated
Jefferies
4.6 out of 5
Jefferies
4.6 out of 5
Buy
$90.00
$90.00
Reiterated
Leerink Swann
3.3 out of 5
Leerink Swann
3.3 out of 5
Hold
$71.00
$71.00
Reiterated
Goldman Sachs
4.3 out of 5
Goldman Sachs
4.3 out of 5
Buy
$70.33
$70.33
Assigned
Raymond James
4.8 out of 5
Raymond James
4.8 out of 5
Buy
$84.00
$84.00
Reiterated
No article available
William Blair
4.3 out of 5
William Blair
4.3 out of 5
Buy
$76.00
$76.00
Reiterated
Citigroup
2.5 out of 5
Citigroup
2.5 out of 5
Hold
-
-
Downgraded
J.P. Morgan
2.8 out of 5
J.P. Morgan
2.8 out of 5
Hold
$70.00
$70.00
Reiterated
No article available
UBS
0.6 out of 5
UBS
0.6 out of 5
Buy
$73.00
$73.00
Reiterated
Deutsche Bank
0.5 out of 5
Deutsche Bank
0.5 out of 5
Hold
$66.00
$66.00
Reiterated
Argus Research
1.6 out of 5
Argus Research
1.6 out of 5
Buy
$85.00
$85.00
Reiterated
Barclays
4.3 out of 5
Barclays
4.3 out of 5
Hold
$68.00
$68.00
Reiterated
Morgan Stanley
0.2 out of 5
Morgan Stanley
0.2 out of 5
Hold
-
-
Reiterated
No article available
Cowen & Co.
2.5 out of 5
Cowen & Co.
2.5 out of 5
Hold
$70.00
$70.00
Downgraded

See the highest rated stocks in the Healthcare sector

Rate Gauge

Blogger Opinions on AbbVie

Blogger Consensus

Bullish: 86%
Sector
Average
Bullish
ABBV Blogger consensus is based on 44 Blogger Opinions, the Blogger consensus is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

  • 47% seekingalpha.com
  • 22% investorplace.com
  • 15% fool.com
  • 16% Others
Article
Distribution

Top Blogger Bearish Opinions

VS

Top Blogger Bullish Opinions

Filter Opinions

Blogger Opinions

Ranking

UpgradeUpgrade to see the 5 most recent opinions
Blogger Opinions
Article
InvestorPlace
4.810973569755771 out of 5
InvestorPlace
Bullish
Bullish
Seeking Alpha
1.160923385747742 out of 5
Seeking Alpha
Bearish
Bearish
Motley Fool
0.1689528270324525 out of 5
Motley Fool
Bullish
Bullish
Seeking Alpha
4.569253931080629 out of 5
Seeking Alpha
Neutral
Neutral
Seeking Alpha
4.94814319170291 out of 5
Seeking Alpha
Bullish
Bullish
Seeking Alpha
4.835229173636668 out of 5
Seeking Alpha
Bullish
Bullish
Seeking Alpha
1.770659083305453 out of 5
Seeking Alpha
Bullish
Bullish
Seeking Alpha
1.4528270324523251 out of 5
Seeking Alpha
Neutral
Neutral
InvestorPlace
1.203579792572767 out of 5
InvestorPlace
Bearish
Bearish
See the 5 highest rated stocks by financial bloggers in this sectorSee highest rated stocks by financial bloggers in this sectorSee highest rated stocks by financial bloggers in this sector
BULLISH
BEARISH

Corporate Insider Activity on AbbVie

Trend: Corporate Insiders Bought Shares Worth $2.66M in the Last 3 Months.

ABBV Insider Transactions

The data in the graph is based on publicly available reports of insider transactions as reported to the SEC.

Insider Confidence Signal

Premium Bannerlock

Upgrade to see Insider confidence signal

Positive

Based on 47 Insider transactions from the last 3 months.

Sector Average
SoldBought

Filters

Position

Action

Ranking

UpgradeUpgrade to see the 5 most recent transactions
Corporate Insider Transactions
SEC
Richard A. Gonzalez
COB & CEO, Director
1.8 out of 5
COB & CEO, Director
1.8 out of 5
Uninformative Sell
$4,664,736
$4,664,736
Read SEC form
William Chase
EVP & CFO
Not Ranked
EVP & CFONot RankedInformative Buy
$1,095,994
$1,095,994
Read SEC form
William Chase
EVP & CFO
Not Ranked
EVP & CFONot RankedUninformative Sell
$2,502,905
$2,502,905
Read SEC form
Edward Liddy
Director
Not Ranked
DirectorNot RankedUninformative Buy
-
-
Read SEC form
Brett Hart
Director
0.9 out of 5
Director
0.9 out of 5
Uninformative Buy
-
-
Read SEC form
Edward Rapp
Director
1 out of 5
Director
1 out of 5
Uninformative Buy
-
-
Read SEC form
Frederick Waddell
Director
4.4 out of 5
Director
4.4 out of 5
Uninformative Buy
-
-
Read SEC form
Glenn Tilton
Director
1.7 out of 5
Director
1.7 out of 5
Uninformative Buy
-
-
Read SEC form
MEYER MELODY B
Director
Not Ranked
DirectorNot RankedUninformative Buy
-
-
Read SEC form
Robert Alpern
Director
Not Ranked
DirectorNot RankedUninformative Buy
-
-
Read SEC form
William Burnside
Director
Not Ranked
DirectorNot RankedUninformative Buy
-
-
Read SEC form
Roxanne Austin
Director
1.8 out of 5
Director
1.8 out of 5
Uninformative Buy
-
-
Read SEC form
Richard A. Gonzalez
COB & CEO, Director
1.8 out of 5
COB & CEO, Director
1.8 out of 5
Uninformative Sell
-
-
Read SEC form
Carlos Alban
EVP, Commercial Operations
0.3 out of 5
EVP, Commercial Operations
0.3 out of 5
Uninformative Sell
$2,881,000
$2,881,000
Read SEC form
Timothy Richmond
SVP HR
1.7 out of 5
SVP HR
1.7 out of 5
Uninformative Sell
$1,465,826
$1,465,826
Read SEC form
Laura Schumacher
EVP
0.6 out of 5
EVP
0.6 out of 5
Uninformative Sell
$2,610,256
$2,610,256
Read SEC form
Michael Robert A.
VP, Controller
Not Ranked
VP, ControllerNot RankedUninformative Sell
$335,068
$335,068
Read SEC form
Michael Robert A.
VP, Controller
Not Ranked
VP, ControllerNot RankedUninformative Buy
-
-
Read SEC form

News Sentiment on AbbVie

Media Buzz in the last 7 days

0
ABBV This
Week
ABBV
Weekly Average
30
This Week:
13 articles
Weekly Average:
10.8 articles

News Sentiment in the last 7 days

Premium Bannerlock

Unlock to see News Sentiment
for ABBV

ABBV This
Week
Sector
Weekly Average
ABBV:
0% Bullish
100% Bearish
Sector Average:
66% Bullish
34% Bearish

News Score

Premium Bannerlock

Upgrade to see the News Score
for ABBV

Neutral

Based on a formula that combines this week’s News Sentiment and Media Buzz
Sector Average
Showing:

Media Coverage Analysis

Keywords mentioned in last week’s articles

  • pioneered research in immune-mediated diseases
  • said Rob Scott
  • fell 2.2%
  • said Michael Severino
  • suffering from this disease
  • ruled in favor of Coherus

See 5 similar stocks with higher news sentiment

Hedge Funds Activity on AbbVie

Trend: Hedge Funds Decreased Holdings by 2.4M Shares Last Quarter.

Hedge Fund Holdings in ABBV

Based on 203 Hedge Funds covered by TipRanks.

Hedge Fund Confidence Signal

Premium Bannerlock

Upgrade to see Hedge
Fund Confidence Signal

Very Negative

Based on activity of 23 Hedge Funds in the recent quarter

SoldBought

Filter Activity

Show Actions

Ranking

Hedge Fund Activity
Highbridge Capital Management LLC
1.2068965517241381 out of 5
New
+100.00%
$4.95M
+100.00%
$4.95M0.07%
Graham Capital Management, L.P.
0.3448275862068967 out of 5
New
+100.00%
$4.03M
+100.00%
$4.03M0.16%
Caxton Associates LP
3.1527093596059115 out of 5
New
+100.00%
$462.64K
+100.00%
$462.64K0.00%
NWQ Investment Management Company, LLC
1.748768472906404 out of 5
New
+100.00%
$275.89K
+100.00%
$275.89K0.00%
Ellington Management Group LLC
1.6995073891625618 out of 5
New
+100.00%
$254.12K
+100.00%
$254.12K0.01%
Perceptive Advisors LLC
1.6256157635467983 out of 5
New
+100.00%
$24.76K
+100.00%
$24.76K0.00%
Pzena Investment Management LLC
3.9901477832512318 out of 5
Added
+19.97%
$271.72K
+19.97%
$271.72K0.00%
Auxier Asset Management
3.004926108374384 out of 5
Added
+9.60%
$1.49M
+9.60%
$1.49M0.31%
Manning & Napier Advisors LLC
1.0837438423645318 out of 5
Added
+4.62%
$10.96M
+4.62%
$10.96M0.08%

Similar Stocks to AbbVie

Company
Price
Market Cap
Sector
Analyst Consensus
Analyst Price Target
JNJ
Johnson & Johnson
$127.520.26 (0.20%)
Healthcare
Moderate Buy
$134.86
(5.76% Upside)
RHHBY
Roche Holding
$34.300.13 (-0.38%)
$189.86B
Healthcare
Moderate Buy
BMY
Bristol Myers
$54.210.11 (0.20%)
Healthcare
Hold
$55.67
(2.69% Upside)
MRK
Merck & Company
$64.550.51 (0.80%)
$176.90B
Healthcare
Moderate Buy
$65.67
(1.74% Upside)
GLPG
Galapagos NV
$84.860.95 (-1.11%)
$3.93B
Healthcare
Moderate Buy
$102.00
(20.20% Upside)